Cabozantinib (Cabometyx)

cabozantinib · Exelixis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cabozantinib (Cabometyx), covering 2026-03-05 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) [Phase 1, Phase 2]